- call +1-201-465-4211
- email sales@mrinsights.biz
Cyazofamid is a kind of sulfamethoxazole fungicides with light yellow solid powder, which has high biological activity against the fungi.
Scope of the Report:
4-methylacetophenone is the main raw materials. Cyazofamid are often applied to treat downy mildew oomycetes diseases.
ISHIHARA SANGYO KAISHA is the largest manufacturer in the global market, which production reached 335 MT in 2016, with the share of 81.91%.
The consumption shares of Japan, China, North America and Europe were 42.79%, 21.52%, 17.11% and 11.74%. Japan is the main import region and other countries need to import from Japan.
The worldwide market for Cyazofamid is expected to grow at a CAGR of roughly 1.6% over the next five years, will reach 90 million US$ in 2024, from 82 million US$ in 2019, according to a new study.
This report focuses on the Cyazofamid in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
ISHIHARA SANGYO KAISHA
Rudong Zhongyi
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Type I
Type II
Market Segment by Applications, can be divided into
Downy Mildew
Oomycetes Diseases
Others
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cyazofamid product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Cyazofamid, with price, sales, revenue and global market share of Cyazofamid in 2017 and 2018.
Chapter 3, the Cyazofamid competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cyazofamid breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Cyazofamid market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Cyazofamid sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Cyazofamid Introduction
1.2 Market Analysis by Type
1.2.1 Type I
1.2.2 Type II
1.3 Market Analysis by Applications
1.3.1 Downy Mildew
1.3.2 Oomycetes Diseases
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 ISHIHARA SANGYO KAISHA
2.1.1 Business Overview
2.1.2 Cyazofamid Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 ISHIHARA SANGYO KAISHA Cyazofamid Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Rudong Zhongyi
2.2.1 Business Overview
2.2.2 Cyazofamid Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Rudong Zhongyi Cyazofamid Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Cyazofamid Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Cyazofamid Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Cyazofamid Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Cyazofamid Manufacturer Market Share in 2018
3.3.2 Top 6 Cyazofamid Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Cyazofamid Market Analysis by Regions
4.1 Global Cyazofamid Sales, Revenue and Market Share by Regions
4.1.1 Global Cyazofamid Sales and Market Share by Regions (2014-2019)
4.1.2 Global Cyazofamid Revenue and Market Share by Regions (2014-2019)
4.2 North America Cyazofamid Sales and Growth Rate (2014-2019)
4.3 Europe Cyazofamid Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Cyazofamid Sales and Growth Rate (2014-2019)
4.5 South America Cyazofamid Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Cyazofamid Sales and Growth Rate (2014-2019)
5 North America Cyazofamid by Country
5.1 North America Cyazofamid Sales, Revenue and Market Share by Country
5.1.1 North America Cyazofamid Sales and Market Share by Country (2014-2019)
5.1.2 North America Cyazofamid Revenue and Market Share by Country (2014-2019)
5.2 United States Cyazofamid Sales and Growth Rate (2014-2019)
5.3 Canada Cyazofamid Sales and Growth Rate (2014-2019)
5.4 Mexico Cyazofamid Sales and Growth Rate (2014-2019)
6 Europe Cyazofamid by Country
6.1 Europe Cyazofamid Sales, Revenue and Market Share by Country
6.1.1 Europe Cyazofamid Sales and Market Share by Country (2014-2019)
6.1.2 Europe Cyazofamid Revenue and Market Share by Country (2014-2019)
6.2 Germany Cyazofamid Sales and Growth Rate (2014-2019)
6.3 UK Cyazofamid Sales and Growth Rate (2014-2019)
6.4 France Cyazofamid Sales and Growth Rate (2014-2019)
6.5 Russia Cyazofamid Sales and Growth Rate (2014-2019)
6.6 Italy Cyazofamid Sales and Growth Rate (2014-2019)
7 Asia-Pacific Cyazofamid by Country
7.1 Asia-Pacific Cyazofamid Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Cyazofamid Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Cyazofamid Revenue and Market Share by Country (2014-2019)
7.2 China Cyazofamid Sales and Growth Rate (2014-2019)
7.3 Japan Cyazofamid Sales and Growth Rate (2014-2019)
7.4 Korea Cyazofamid Sales and Growth Rate (2014-2019)
7.5 India Cyazofamid Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Cyazofamid Sales and Growth Rate (2014-2019)
8 South America Cyazofamid by Country
8.1 South America Cyazofamid Sales, Revenue and Market Share by Country
8.1.1 South America Cyazofamid Sales and Market Share by Country (2014-2019)
8.1.2 South America Cyazofamid Revenue and Market Share by Country (2014-2019)
8.2 Brazil Cyazofamid Sales and Growth Rate (2014-2019)
8.3 Argentina Cyazofamid Sales and Growth Rate (2014-2019)
8.4 Colombia Cyazofamid Sales and Growth Rate (2014-2019)
9 Middle East and Africa Cyazofamid by Countries
9.1 Middle East and Africa Cyazofamid Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Cyazofamid Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Cyazofamid Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Cyazofamid Sales and Growth Rate (2014-2019)
9.3 Turkey Cyazofamid Sales and Growth Rate (2014-2019)
9.4 Egypt Cyazofamid Sales and Growth Rate (2014-2019)
9.5 Nigeria Cyazofamid Sales and Growth Rate (2014-2019)
9.6 South Africa Cyazofamid Sales and Growth Rate (2014-2019)
10 Global Cyazofamid Market Segment by Type
10.1 Global Cyazofamid Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Cyazofamid Sales and Market Share by Type (2014-2019)
10.1.2 Global Cyazofamid Revenue and Market Share by Type (2014-2019)
10.2 Type I Sales Growth and Price
10.2.1 Global Type I Sales Growth (2014-2019)
10.2.2 Global Type I Price (2014-2019)
10.3 Type II Sales Growth and Price
10.3.1 Global Type II Sales Growth (2014-2019)
10.3.2 Global Type II Price (2014-2019)
11 Global Cyazofamid Market Segment by Application
11.1 Global Cyazofamid Sales Market Share by Application (2014-2019)
11.2 Downy Mildew Sales Growth (2014-2019)
11.3 Oomycetes Diseases Sales Growth (2014-2019)
11.4 Others Sales Growth (2014-2019)
12 Cyazofamid Market Forecast (2019-2024)
12.1 Global Cyazofamid Sales, Revenue and Growth Rate (2019-2024)
12.2 Cyazofamid Market Forecast by Regions (2019-2024)
12.2.1 North America Cyazofamid Market Forecast (2019-2024)
12.2.2 Europe Cyazofamid Market Forecast (2019-2024)
12.2.3 Asia-Pacific Cyazofamid Market Forecast (2019-2024)
12.2.4 South America Cyazofamid Market Forecast (2019-2024)
12.2.5 Middle East and Africa Cyazofamid Market Forecast (2019-2024)
12.3 Cyazofamid Market Forecast by Type (2019-2024)
12.3.1 Global Cyazofamid Sales Forecast by Type (2019-2024)
12.3.2 Global Cyazofamid Market Share Forecast by Type (2019-2024)
12.4 Cyazofamid Market Forecast by Application (2019-2024)
12.4.1 Global Cyazofamid Sales Forecast by Application (2019-2024)
12.4.2 Global Cyazofamid Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Cyazofamid Picture
Table Product Specifications of Cyazofamid
Figure Global Sales Market Share of Cyazofamid by Types in 2018
Table Cyazofamid Types for
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
